EXPERIENCE

Jennifer's representative experience includes advising:

M&A and Corporate Structuring

• Cadence Design Systems, Inc. on its US$1.24 billion acquisition of BETA CAE
• IHS Markit on its joint venture with PIMCO, Man Property Holdings, State Street, and Microsoft to set up a new technology-led company, HUB, to build a cloud-based operating platform aimed at transforming asset managers’ operations technology
• Meta in connection with multiple transactions, including its:
  • Acquisition of Mapillary, a Sweden-based company engaged in providing crowd sourcing map photos
  • Acquisition by Oculus VR, a subsidiary of Facebook, of Beat Games, a Czech-based game studio
  • Acquisition of Unit2 Games, an England-based game creation studio and sharing platform
• Easybrain, a leading mobile game developer with a core focus on puzzle and logic games, in its acquisition by Embracer Group
• BenevolentAI, a leading, clinical-stage AI-enabled drug discovery company, on its business combination with Odyssey Acquisition S.A., a Euronext Amsterdam-listed special purpose acquisition company
• Centricus Acquisition Corp., a special purpose acquisition company, on its US$1 billion business combination with Arqit, a London-based developer of a quantum encryption platform
• Threads on its divestment of a majority stake to Chalhoub
• Leonard Green & Partners and its portfolio company CPA Global, in connection with multiple transactions, including its:
  • US$6.8 billion combination with Clarivate Plc, a leader in providing trusted information and insights to accelerate the pace of innovation
  • Acquisition of ipan/Delegate Group, a Germany-based provider of intellectual property (IP) annuity renewal services
• Avalon Battery Corporation on its US$36 million reverse takeover of redT energy
• GlaxoSmithKline in connection with multiple transactions, including its:
  • Divestment of assets relating to the Bialcol and Cibalgina brands in Italy to Vemedia
  • Divestment of five over-the-counter dermatology brands and one pediatric cough remedy brand to the STADA Group
  • Divestment of certain North American consumer health assets to Crown Laboratories
• Peloton Advantage, a portfolio company of Amulet Capital Partners, in the acquisition of Open Health Communications, a UK-based provider of healthcare communications and market access services
• Telenor on its €2.8 billion sale of its assets in Central and Eastern Europe (CEE) to PPF Group
• John Deere in connection with its acquisition of Blue River Technology, a company specializing in machine learning technology for agricultural applications (US$305 million)
• CH2M, a design engineering services firm, in connection with its sale to Jacobs Engineering (US$2.85 billion)
• Broadcom Inc. (formerly Avago Technologies Limited) in connection with multiple transactions, including its:
  • Domestication to the United States and attempted hostile takeover of Qualcomm for US$117 billion
  • Acquisition of Brocade Communications Systems Inc. for US$5.9 billion
  • US$37 billion acquisition of Broadcom Corporation
  • US$606 million acquisition of Emulex Corporation
• Data Device Corporation (DDC), a portfolio company of Behrman Capital, in its US$1 billion sale to TransDigm Group Incorporated
• Cleversafe, Inc., a provider of cloud-based data storage solutions, in its sale to IBM

Sports Transactions

• MSD UK Holdings Limited, lender to West Bromwich Albion Group Limited, in connection with the indirect sale of 87.8% of West Bromwich Albion Football Club to Bilkul Football WBA, LLC
• TWG Global and Billie Jean King Enterprises on their partnership agreement with the International Tennis Federation to form the Billie Jean King Cup Limited
• Endeavor Group Holdings, Inc. on its acquisition of Madrid Open tennis tournament and the Acciona Open de España golf tournament

Capital Markets

• The independent directors of Vedanta Resources plc in connection with the possible offer by Volcan Investments Ltd for the remaining issued and to be issued share capital of Vedanta not already held by Volcan
• AMD in its 100 million shares of common stock listed on NASDAQ and US$805 million offering of 2.125% convertible senior notes
• Credit Suisse on ObsEva SA’s initial public offering of 6.45 million shares of common stock